Disc Medicine’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Disc Medicine is a biotechnology company that develops hepcidin therapies to restore red blood cell production for hematologic diseases. Read more

John Quisel's photo - President & CEO of Disc Medicine

President & CEO

John Quisel

CEO Approval Rating

90/100

Founded:

2017

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Diatron has been one of Disc Medicine's top competitors. Diatron is a Private company that was founded in 1989 in Budapest, Budapest. Like Disc Medicine, Diatron also competes in the Biotechnology sector. Compared to Disc Medicine, Diatron has 330 more employees.

Silence Therapeutics is seen as one of Disc Medicine's biggest rivals. Silence Therapeutics is a Public company that was founded in London, England in 1994. Like Disc Medicine, Silence Therapeutics also operates in the Biotechnology sector. Silence Therapeutics has 26 more employees vs. Disc Medicine.

Spectrum Pharmaceuticals is perceived as one of Disc Medicine's biggest rivals. Spectrum Pharmaceuticals was founded in Henderson, Nevada} in 1987. Like Disc Medicine, Spectrum Pharmaceuticals also competes in the Biotechnology space. Compared to Disc Medicine, Spectrum Pharmaceuticals generates $42.8M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Disc Medicine?

Acquisitions

No recent acquisitions found related to Disc Medicine

Disc Medicine Funding History

$0$50M

Since Disc Medicine was founded in 2017, it has participated in 2 rounds of funding. In total Disc Medicine has raised $50.0M. Disc Medicine's last funding round was on Oct 2019 for a total of $50.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Oct 2019
$50M

Novo Holdings A/S

Seed
Oct 2017
--

Total Funding: $50M

Since Disc Medicine was founded in 2017, it has participated in 2 rounds of funding. In total Disc Medicine has raised $50.0M. Disc Medicine's last funding round was on Oct 2019 for a total of $50.0M

Investments

No recent investments found related to Disc Medicine

Disc Medicine News

October 29, 2019BioSpace

Disc Medicine Expands Pipeline Focused on Hepcidin Pathway

Enters into exclusive agreement with AbbVie for series of Hemojuvelin Antagonist Monoclonal Antibodie... See more »

Disc Medicine Press Releases

Headquarters

300 Technology Square

Cambridge, Massachusetts02139

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Disc Medicine is a biotechnology company that develops hepcidin therapies to restore red blood cell production for hematologic diseases. Disc Medicine was founded in 2017. Disc Medicine's headquarters is located in Cambridge, Massachusetts, USA 02139....

CEO

Disc Medicine's President & CEO, John Quisel, currently has an approval rating of 90%. Disc Medicine's primary competitors are Diatron, Silence Therapeutics & Spectrum Pharmaceuticals.

Website

discmedicine.com

Frequently Asked Questions about Disc Medicine

  1. When was Disc Medicine founded?

    Disc Medicine was founded in 2017
  2. Who is Disc Medicine's CEO?

    Disc Medicine's CEO is John Quisel
  3. How much revenue does Disc Medicine generate?

    Disc Medicine generates $3M in revenue
  4. How much funding does Disc Medicine have?

    Disc Medicine has historically raised $50M in funding
  1. Where is Disc Medicine's headquarters?

    Disc Medicine's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Disc Medicine have?

    Disc Medicine has 20 employees
  3. What sector does Disc Medicine operate in?

    Disc Medicine is in Biotechnology
  4. Who are Disc Medicine's competitors?

    Disc Medicine's top competitors are Diatron, Silence Therapeutics, Spectrum Pharmaceuticals